RecruitingNot ApplicableNCT05562778

Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

Evaluation of a Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment in an Underserved Gynecology Population

Sponsor

Weill Medical College of Cornell University

Enrollment

150 participants

Start Date

Jan 15, 2023

Study Type

INTERVENTIONAL

Conditions

Hereditary Cancer Syndrome Gynecologic Cancer

Summary

In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of harboring a familial cancer syndrome in an all-Medicaid gynecology clinic. Furthermore, the investigators aim to evaluate facilitators of inequity in regard to patient access to and utilization of genetic testing services.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a text-message chatbot can help patients at a gynecology clinic understand their family's history of cancer and identify whether they may be at risk for a hereditary cancer syndrome (like BRCA-related cancers). If the chatbot identifies a risk, it can connect the patient with genetic counseling resources — making screening faster and easier. You may be eligible if... - You are 18 years of age or older - You have a new patient appointment scheduled at the gynecology clinic - You speak and read English - You have a phone with texting capability - You have not previously had genetic testing for hereditary cancer syndromes You may NOT be eligible if... - You are under 18 years old - You have already had genetic testing for hereditary cancer - You cannot read or speak English - You do not have a phone with texting capability Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERChatbot

A chatbot is a software program designed to simulate human conversation, typically via text. Chatbots utilize natural language processing to gather patient data, anticipate questions, and predict responses. In this study, the Chatbot will simulate a text-like conversation with patients via a smartphone and use this platform to deal with the time-consuming nature of family history collection. The chatbots can then triage the collected family history against medical guidelines to determine which patients warrant genetic testing. For those patients meeting criteria for genetic testing, the chatbot can offer pre-test education and assist physicians with ordering genetic testing for interested patients meeting high-risk criteria.